SEC Form 4 · accession 0001144204-16-077573
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J. F. Wernicke
Officer — Chief Medical Officer
Period of report
Jan 25, 2016
Accepted (ET)
Jan 28, 2016 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 25, 2016 | P | 620 | $1.12 | A | 620 | D | |
| Common Stock | Jan 25, 2016 | P | 980 | $1.13 | A | 1,600 | D | |
| Common Stock | Jan 25, 2016 | P | 8,400 | $1.11 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.